Ftse Mib
32.665,21
-2,81%
DAX
18.002,02
-1,43%
S&P 500
5.431,60
-0,04%
NASDAQ
17.688,88
0,12%
Bitcoin
66.054,66
0,07%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ CV Therapeutics (MM) (CVTX) CV Therapeutics (MM) (CVTX) Notizie

CVTX

CV Therapeutics (CVTX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CVTX
DataOraFonteTitoloSimboloCompagnia
17/04/200923:01Edgar (US Regulatory)Termination of Registration of a Class of Security under Section 12(g) (15-12G)NASDAQ:CVTXCV Therapeutics (MM)
17/04/200922:32Edgar (US Regulatory)(25-NSE)NASDAQ:CVTXCV Therapeutics (MM)
17/04/200922:15Business WireGilead Sciences Completes Acquisition of CV TherapeuticsNASDAQ:CVTXCV Therapeutics (MM)
17/04/200919:29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
15/04/200921:54Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:CVTXCV Therapeutics (MM)
14/04/200912:06Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:CVTXCV Therapeutics (MM)
09/04/200922:53Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:CVTXCV Therapeutics (MM)
09/04/200921:11Edgar (US Regulatory)Schedule 13GNASDAQ:CVTXCV Therapeutics (MM)
08/04/200916:49MarketwiredAnalystChoice.com Free Investment Opinion on PPDI, MEDX, CVTX and OSIPNASDAQ:CVTXCV Therapeutics (MM)
06/04/200922:12Edgar (US Regulatory)Amended Annual Report (10-K/A)NASDAQ:CVTXCV Therapeutics (MM)
18/03/200922:05MarketwiredCV Therapeutics' Board of Directors Recommends Stockholders Accept Gilead Sciences' $20.00 per Share Cash Tender OfferNASDAQ:CVTXCV Therapeutics (MM)
18/03/200921:44Edgar (US Regulatory)Statement of Ownership: Solicitation (SC 14D9)NASDAQ:CVTXCV Therapeutics (MM)
18/03/200921:42Edgar (US Regulatory)Tender offer statement by Third Party (SC TO-T)NASDAQ:CVTXCV Therapeutics (MM)
18/03/200918:53Edgar (US Regulatory)Current report filing (8-K)NASDAQ:CVTXCV Therapeutics (MM)
18/03/200918:52Edgar (US Regulatory)Written communication relating to an issuer or third party (SC TO-C)NASDAQ:CVTXCV Therapeutics (MM)
17/03/200914:07MarketwiredRun of 100% Profitable Stock Alerts Marches on for BullTradeNASDAQ:CVTXCV Therapeutics (MM)
16/03/200922:13Edgar (US Regulatory)Additional Proxy Soliciting Materials - Non-Management (definitive) (DFAN14A)NASDAQ:CVTXCV Therapeutics (MM)
16/03/200921:57Dow Jones NewsMARKET SNAPSHOT: Corporate Cash Reserves, Cheap Stocks Could Trigger More M&ANASDAQ:CVTXCV Therapeutics Inc.
16/03/200921:01MarketwiredCV Therapeutics Announces Presentations at the American College of Cardiology 58th Annual Scientific SessionNASDAQ:CVTXCV Therapeutics (MM)
16/03/200920:01Dow Jones NewsUPDATE: US Drug Sector Rises After Bernanke CommentsNASDAQ:CVTXCV Therapeutics Inc.
16/03/200919:49Dow Jones NewsMARKET SNAPSHOT: Corporate Cash Warchests, Cheap Stocks Could Trigger More M&ANASDAQ:CVTXCV Therapeutics Inc.
16/03/200916:10Dow Jones NewsDrug Sector Rises As Fed Chief Bernanke's Upbeat On RecessionNASDAQ:CVTXCV Therapeutics Inc.
16/03/200910:12Dow Jones NewsUPDATE:Astellas Pharma Abandons Offer To Buy CV TherapeuticsNASDAQ:CVTXCV Therapeutics Inc.
16/03/200908:08Dow Jones NewsAstellas Pharma: Withdrawing Offer To Buy CV TherapeuticsNASDAQ:CVTXCV Therapeutics Inc.
16/03/200907:42Business WireAstellas to Terminate Offer for CV TherapeuticsNASDAQ:CVTXCV Therapeutics (MM)
13/03/200913:45Dow Jones NewsGenentech-Roche Deal Shows Attraction Of Biotech AssetsNASDAQ:CVTXCV Therapeutics Inc.
12/03/200922:03Edgar (US Regulatory)Written communication by the subject company relating to a third party tender offer (SC14D9C)NASDAQ:CVTXCV Therapeutics (MM)
12/03/200919:15PR Newswire (US)CV Therapeutics' Board of Directors Rejects Astellas' Tender OfferNASDAQ:CVTXCV Therapeutics (MM)
12/03/200915:06Dow Jones NewsUPDATE: Gilead To Buy CV Therapeutics For $1.4 BillionNASDAQ:CVTXCV Therapeutics Inc.
12/03/200914:22Dow Jones NewsGilead To Buy CV Therapeutics For $1.4 Billion In White-Knight BidNASDAQ:CVTXCV Therapeutics Inc.
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CVTX

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
STLAM
Stellantis NV
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ENEL
Enel
BIT
ENI
Eni
BIT
BPE
Bper Banca
BIT
LDO
Leonardo
BIT
STMMI
ST Microelectronics
BIT
BAMI
Banco BPM
BIT
RACE
Ferrari NV
BIT
SPM
Saipem
BIT
G
Generali
BIT
NEXI
Nexi S.p.A
BIT
TIT
Telecom Italia
BIT
PST
Poste Italiane S.p.a
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network